Hone Health reports on 12 longevity trends for 2026 that shift focus from elite biohacking to evidence-based health practices ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

Abstract: There exist various categories of uncertain information, and their corresponding methods of aggregation may also vary. At present, there exists a dearth of specifically tailored techniques ...